T. Kusumoto et al., REVERSAL OF DRUG-RESISTANCE BY EXPOSURE OF MCF-7 OR MCF-7 CDDP HUMAN BREAST-CARCINOMA CELLS TO SR-4233 OR ETANIDAZOLE UNDER HYPOXIC CONDITIONS, International journal of oncology, 3(2), 1993, pp. 205-211
Drug resistance is a major problem in cancer therapy. The MCF-7/CDDP c
ell line, a subline of the MCF-7 human breast carcinoma cell line whic
h is resistant to cis-diamminedichloroplatinum(II), is also resistant
to carboplatin, D-tetraplatin and to a lesser degree to melphalan, thi
otepa and BCNU compared with the MCF-7 parental cell line. This resist
ance persists both under normally oxygenated conditions and after 2 h
of exposure to hypoxic conditions prior to exposure to the antitumor a
lkylating agents under normally oxygenated conditions. When the MCF-7
parental cells and MCF-7/CDDP cells were treated with SR-4233 (20 muM)
or etanidazole (5 mM) for 2 h prior to and during exposure to the ant
itumor alkylating agents there was no change in the sensitivity and re
sistance patterns of the cell lines. However, if the MCF-7 parental ce
lls and the MCF-7/CDDP cells were exposed to SR-4233 (20 muM) or etani
dazole (5 mM) for 2 h under hypoxic conditions followed by release of
the hypoxia and exposure to the antitumor alkylating agents for 1 h un
der normally oxygenated conditions the resistance of the MCF-7/CDDP wa
s reversed so that both the MCF-7 parental and MCF-7/CDDP cell lines w
ere essentially equally sensitive to the six antitumor alkylating agen
ts. These results indicate that non-cytotoxic concentrations of modula
tors such as SR-4233 or etanidazole may be useful in reversing resista
nce to the